Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 397 of 673

Advanced search

🇺🇸Jul 29Industryyprime.comTier 1 · Company source

eCOA for Dermatology Clinical Trials: Automated Workflows in a Global Phase 3 Psoriasis Study

YPrimeOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Keeping drugs free of contaminants – pharmaceutical makers filter medications through tiny pores to keep them sterile and safe

Japan TodayOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

BioMarin and n-Lorem Foundation Enter Collaboration | PharmExec

Pharmaceutical ExecutiveOriginal source

🇺🇸Jul 29CROppd.comTier 2 · Direct publisher

Transportability in Health Technology Assessment

Thermo Fisher PPDOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Advances First Dual-Payload ADC into Clinical Trials for Solid Tumours

BioPharma APACOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Biotech subsidiary raises $130 million to treat this painful condition

The Business JournalsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Expands Global Licensing Push for Botanical Therapy Targeting Enlarging BPH Market

BioPharma APACOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Mumbai’s Clubs Face FDA Heat! CCI, MIG and Others Lose Food Licences: Cockroaches, Flies and Mouldy Food Found

Times NowOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Food licences of 5 high-profile Mumbai clubs suspended over hygiene violations

India TodayOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (VRXA) Shareholders Approve Corporate Governance, Financing Measures

Yahoo FinanceOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Labels

Label and Narrow WebOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.01, Implies 9% Upside

TradingViewOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight

The Manila TimesOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

FDA suspends food licences of five Mumbai clubs over major hygiene, food safety violations

Business TodayOriginal source

🌍Jul 29Industryeledon.comTier 1 · Company source

Efforts Address Immune Suppression in Islet Cell Transplants

Eledon PharmaceuticalsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Peli BioThermal, PAXAFE Partnership Signals AI-Powered Cold Chain Future

Pharmaceutical CommerceOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Developer to seek approval in Canada for ALS treatment aiding survival

ALS News TodayOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Licences of These 5 Clubs in Mumbai Over Food Safety Violations; Check Names Here

LatestLYOriginal source

🌍Jul 29Researchindicalab.comTier 2 · Direct publisher

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis

Indica LabsOriginal source

🌍Jul 29Researchindicalab.comTier 2 · Direct publisher

Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI

Indica LabsOriginal source

🇺🇰Jul 29Researchmed.cam.ac.ukTier 2 · Direct publisher

GSK to open £400m R&D centre in Cambridge to strengthen immunology research

University of Cambridge - Clinical Medicine NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

FDA panel to consider previously spurned drugs

PoliticoOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Taiwan biotech looks outward in next phase of growth

BioWorld NewsOriginal source

🌍Jul 29discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist

PR NewswireOriginal source

🇮🇹Jul 28Industryrecordati.comTier 1 · Company source

RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%

RecordatiOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Exclusive: Hanmi Pharmaceutical Unveils First Domestic Obesity Drug 'EPPE'

조선일보Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Piper Sandler Raises Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $44.00

MarketBeatOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it

Crypto BriefingOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Fedrigoni addresses evolving pharmaceutical label industry

Label and Narrow WebOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Biotech Division of Greenland Mines Announces Issuance of Patent in Canada for the Klotho Gene Therapy Platform Technology for Alzheimer’s and Aging

InvestorNewsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $130 Million Series B Financing

marketscreener.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Record Chinese biotech out-licensing meets rising US scrutiny

South China Morning PostOriginal source

🇺🇰Jul 28Researchpirbright.ac.ukTier 2 · Direct publisher

The Gordon Memorial Lecture: A paradigm shift in high pathogenicity avian influenza and perspectives for the future

The Pirbright Institute (Virology)Original source

🇺🇰Jul 28Researchpirbright.ac.ukTier 2 · Direct publisher

Stability of influenza viruses in the milk of cows and sheep

The Pirbright Institute (Virology)Original source

🇺🇰Jul 28Researchpirbright.ac.ukTier 2 · Direct publisher

A G57 (BJ/94-like) H9N2 avian influenza virus exhibits enhanced replication and tissue dissemination in chickens compared with a G1-B virus

The Pirbright Institute (Virology)Original source

🇺🇰Jul 28Researchpirbright.ac.ukTier 2 · Direct publisher

Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication

The Pirbright Institute (Virology)Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Action Against Mumbais Elite Clubs: CCI, Juhu Gymkhanas, MIG, Willingdon Lose FSSAI Licences

Free Press JournalOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

PharmTech.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

MapLight's schizophrenia candidate clears one bar but misses another

The Pharma LetterOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Danaher (DHR)

The Globe and MailOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Leadership changes afoot at two CGT biotechs

Pharmaceutical TechnologyOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.2, Implies 10% Upside

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Paradigm Biopharmaceuticals (ASX:PAR) Advances Phase 3 Osteoarthritis Program as Clinical Execution Remains Key Focus

KalkineOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Questex’s Fierce Pharma Unveils Fierce Pharma Week’s 2026 Conference Program, Explores What’s Next in the Pharmaceutical Industry

The Manila TimesOriginal source

🇺🇸Jul 28Researchrarediseases.orgTier 2 · Direct publisher

National Organization for Rare Disorders Expands Rare Disease Centers of Excellence Network

NORD Rare DiseasesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Cracks Down On Mumbai Clubs For Food Safety Violations

rediff.comOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Alnylam’s stock is down 30% despite a booming biotech market. Here’s why

Endpoints NewsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Grants Fast Track Designation to HTX-001 for nHCM

HCPLiveOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

CHMP backs Roche’s Susvimo as first continuous nAMD therapy

European Pharmaceutical ReviewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Peli BioThermal Partners with PAXAFE to Redefine Pharmaceutical Cold Chain Intelligence

PR NewswireOriginal source

🇺🇸Jul 28Devicespathai.comTier 1 · Company source

PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configurability

PathAIOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard

Fierce BiotechOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

China’s biotech rise to face challenges from US policy responses

PharmaLiveOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Brewing Up Biotech: Tea Catechins and Their Anti-Aging Impact

Cosmetics & ToiletriesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

BrainStorm Appoints Former FDA Official Peter Pitts Executive Chairman to Lead Phase 3 ALS Strategy

citybizOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Potential Retatrutide Benefits You Should Know About

GoodRxOriginal source

🇺🇸Jul 28Research5amventures.comTier 2 · Direct publisher

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

5AM VenturesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Navigating Technology Transfer in Pharma and Biotech

Technology NetworksOriginal source